These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27904585)

  • 21. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria.
    Charles PE; Ladoire S; Aho S; Quenot JP; Doise JM; Prin S; Olsson NO; Blettery B
    BMC Infect Dis; 2008 Mar; 8():38. PubMed ID: 18366777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of procalcitonin for excluding bloodstream infection: results of a retrospective study and utility of a rapid, quantitative test for procalcitonin.
    Wang H; Yin F; Shen DX; Zhang YJ; Luo YP; Liu CJ; Wang KF; Zhou G; Ye LY; Chen G; Wang XN
    J Int Med Res; 2013 Oct; 41(5):1671-81. PubMed ID: 24065454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative diagnostic test evaluation of serum procalcitonin and C-reactive protein in suspected bloodstream infections in children with cancer.
    R Nath S; Jayapalan S; Nair H; Kusumakumary P; Prema NS; Priyakumari T; Rajamohanan K
    J Med Microbiol; 2017 May; 66(5):622-627. PubMed ID: 28504925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma procalcitonin levels remain low at the onset of gram-positive bacteremia regardless of severity or the presence of shock: A retrospective analysis of patients with detailed clinical characteristics.
    Koizumi Y; Sakanashi D; Ohno T; Nakamura A; Yamada A; Shibata Y; Shiota A; Kato H; Hagihara M; Asai N; Watarai M; Murotani K; Yamagishi Y; Suematsu H; Mikamo H
    J Microbiol Immunol Infect; 2021 Dec; 54(6):1028-1037. PubMed ID: 32893142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Procalcitonin Accuracy for the Distinction Between Gram-Negative and Gram-Positive Bacterial Sepsis in Burn Patients.
    Cabral L; Afreixo V; Meireles R; Vaz M; Frade JG; Chaves C; Caetano M; Almeida L; Paiva JA
    J Burn Care Res; 2019 Jan; 40(1):112-119. PubMed ID: 30481299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cut-off levels of procalcitonin and C-reactive protein and the kinetics of mean platelet volume in preterm neonates with sepsis.
    Aydemir C; Aydemir H; Kokturk F; Kulah C; Mungan AG
    BMC Pediatr; 2018 Aug; 18(1):253. PubMed ID: 30068303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of Procalcitonin to Distinguish Fungal from Bacterial Infections in Patients with Systemic Lupus Erythematosus.
    He S; Ma J; Fan C; Tang C; Chen Y; Xie C
    Infect Drug Resist; 2021; 14():4773-4781. PubMed ID: 34815675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pcv-aCO
    Wang ZH; Wei XB; Liao XL; Chen SL; Guo WX; Hu PH; Wu Y; Liao YW; Qin TH; Wang SH
    Am J Med Sci; 2022 Dec; 364(6):752-757. PubMed ID: 35914578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnostic and predictive value of critical illness scores and biomarkers in bloodstream infection-associated pneumonia].
    Yan S; Sun L; Lian R; Shen M; Zhao X; Zhang G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):681-685. PubMed ID: 32684212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ability of serum procalcitonin to distinguish focus of infection and pathogen types in patients with bloodstream infection.
    Leng Y; Chen C; Zhang Y; Luo C; Liu B
    Ann Transl Med; 2019 Apr; 7(7):135. PubMed ID: 31157256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Procalcitonin, C-reactive protein and serum lactate dehydrogenase in the diagnosis of bacterial sepsis, SIRS and systemic candidiasis.
    Miglietta F; Faneschi ML; Lobreglio G; Palumbo C; Rizzo A; Cucurachi M; Portaccio G; Guerra F; Pizzolante M
    Infez Med; 2015 Sep; 23(3):230-7. PubMed ID: 26397291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic value of serum procalcitonin for infection in the immunocompromised critically ill patients with suspected infection].
    Yu X; Ma X; Ai Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jun; 27(6):477-83. PubMed ID: 26049187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic and prognostic value of procalcitonin in patients with sepsis.
    Mustafić S; Brkić S; Prnjavorac B; Sinanović A; Porobić Jahić H; Salkić S
    Med Glas (Zenica); 2018 Aug; 15(2):93-100. PubMed ID: 30047536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Significance of Interleukin-6 in the Diagnosis of Sepsis and Discriminating Sepsis Induced by Gram-negative Bacteria.
    Shao WX; Yu DJ; Zhang WY; Wang XJ
    Pediatr Infect Dis J; 2018 Aug; 37(8):801-805. PubMed ID: 30004393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic and prognostic values of serum procalcitonin and C-reactive protein in patients of bacterial sepsis].
    Huang X; Wang J; Li H
    Zhonghua Yi Xue Za Zhi; 2014 Jul; 94(27):2106-9. PubMed ID: 25327855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Diagnostic Value of Procalcitonin Versus Other Biomarkers in Prediction of Bloodstream Infection.
    Pan YP; Fang YP; Xu YH; Wang ZX; Shen JL
    Clin Lab; 2017 Feb; 63(2):277-285. PubMed ID: 28182347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
    Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
    J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens.
    Stoma I; Karpov I; Uss A; Rummo O; Milanovich N; Iskrov I
    Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):15-21. PubMed ID: 27793578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective evaluation of serum procalcitonin in critically ill patients with suspected sepsis- experience from a tertiary care hospital in Pakistan.
    Ahmed S; Siddiqui I; Jafri L; Hashmi M; Khan AH; Ghani F
    Ann Med Surg (Lond); 2018 Nov; 35():180-184. PubMed ID: 30319777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients.
    Svaldi M; Hirber J; Lanthaler AI; Mayr O; Faes S; Peer E; Mitterer M
    Br J Haematol; 2001 Oct; 115(1):53-7. PubMed ID: 11722409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.